Higher circulating testosterone levels could directly activate tumor AR activities, but tumors can also develop ligand-independent sustained AR activities through mechanisms such as AR mutation, gene amplification, or even intratumoral androgen synthesis [60]. This evidence concerns the gene AR and neoplasm.